**Core Concept**
Trientine is a chelating agent used in the treatment of Wilson's disease, a genetic disorder characterized by excessive accumulation of copper in the body. It works by forming a stable complex with copper ions, thereby facilitating their excretion from the body.

**Why the Correct Answer is Right**
Trientine is a second-generation chelating agent that is more effective and safer than penicillamine, another chelating agent used for Wilson's disease. It is particularly useful in patients who cannot tolerate penicillamine due to its side effects. Trientine is administered orally and is well absorbed from the gastrointestinal tract. The mechanism of action of trientine involves the formation of a stable copper-trientine complex, which is then excreted in the urine.

**Why Each Wrong Option is Incorrect**
**Option A:** This statement is incorrect because trientine is not a copper-chelating agent that is also a vasodilator. While it does chelate copper, its primary mechanism is not related to vasodilation.
**Option B:** This statement is incorrect because trientine is not a first-line treatment for hemochromatosis, a condition characterized by excessive iron accumulation in the body. Chelators like deferiprone and deferoxamine are more commonly used for this condition.
**Option C:** This statement is incorrect because trientine is not a treatment for lead poisoning. Chelators like succimer and penicillamine are more commonly used for lead poisoning.

**Clinical Pearl / High-Yield Fact**
Trientine is a safer alternative to penicillamine for the treatment of Wilson's disease, but it is not without side effects. Common side effects include gastrointestinal disturbances, rash, and fever.

**Correct Answer: C. Trientine is not a treatment for lead poisoning.**